Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H15F3N5O4P |
InChIKeyBORUAKGKEGMPAA-MGPLVRAMSA-N |
CAS Registry194798-86-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Actinomycosis | Phase 1 | China | 06 May 2025 | |
Fusariosis | Phase 1 | China | 06 May 2025 | |
Candidemia | Phase 1 | China | 02 Jan 2018 | |
Invasive aspergillosis | Phase 1 | China | 02 Jan 2018 |